Clin2
NCT07662200Possibly a fitNot yet recruiting

Preventing nausea from chemotherapy for germ cell cancer

Germ Cell Cancer

Treatments studied

Part of Cancer clinical trials.

This study tests a simple medication regimen to help prevent nausea and vomiting during chemotherapy for germ cell cancer, which may improve your comfort during treatment.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
10 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have a type of cancer called germ cell cancer.
  • You will receive chemotherapy with a standard 5-day regimen that includes cisplatin, and it will be given at an outpatient clinic.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05690802Recruiting
Test palonosetron to prevent nausea from chemotherapy

This trial studies whether palonosetron helps prevent nausea and vomiting caused by chemotherapy that has a moderate risk of vomiting. It may help you feel more comfortable during chemo and avoid treatment interruptions from severe nausea.

Xi'an, Shaan'xi
NCT07482891Recruiting· Phase 4
Preventing nausea and vomiting from multi-day chemo

This study tests if two medicines given together, fosaprepitant and palonosetron, can prevent nausea and vomiting caused by strong chemotherapy given over several days. It's for people who have never had chemo before and are about to start a multi-day treatment for a solid tumor.

Shanghai, Shanghai Municipality
NCT07617246Recruiting· Phase 2
Preventing nausea from cancer treatment with new medications

This study tests two medications (fosrolapitant and palonosetron) to prevent severe nausea and vomiting in patients with esophageal or lung cancer who are receiving chemotherapy combined with immunotherapy. If the medications work well, they could help patients feel better during treatment and complete their cancer care more comfortably.

Hangzhou, Zhejiang
NCT06417567Recruiting
Preventing nausea and vomiting after GI cancer surgery

This study tests whether the medication NEPA (Netupitant and Palonosetron) can prevent nausea and vomiting in people who have had surgery for liver, gallbladder, or pancreatic cancer. It may help those who want to avoid post-surgery sickness.

Tianjin, Tianjin Municipality
NCT06080880Recruiting
Testing weekly vs every 3 weeks ondansetron for chemo nausea

This trial compares two schedules of ondansetron (a nausea prevention drug) in people getting cisplatin chemotherapy plus a PD-1 inhibitor. It aims to find which dosing schedule works best to prevent nausea and vomiting.

Wuhan, Hubei
NCT07699276Recruiting· Phase 2
Steroid-sparing nausea drug combo for high-dose chemo

This trial tests if combining two anti-nausea drugs (olanzapine and palonosetron) can prevent vomiting and nausea without using steroids in people receiving high-dose cisplatin chemotherapy for their first time.

Bangkok

Hear when a new Germ Cell Cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.